RGACX | VAFNX | RGACX / VAFNX | |
Total Expense Ratio | 0.94 | 0.70 | 134% |
Annual Report Gross Expense Ratio | 0.94 | 0.70 | 134% |
Fund Existence | 23 years | 15 years | - |
Gain YTD | 18.697 | 15.264 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 343B | 18.5B | 1,854% |
Annual Yield % from dividends | 0.07 | 0.00 | - |
Returns for 1 year | 14.51 | 20.13 | 72% |
Returns for 3 years | 72.98 | 99.06 | 74% |
Returns for 5 years | 40.62 | 23.40 | 174% |
Returns for 10 years | 99.82 | 114.79 | 87% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BFK | 9.97 | 0.05 | +0.50% |
BlackRock Municipal Income Trust | |||
MEDX | 31.62 | 0.05 | +0.17% |
Horizon Kinetics Medical ETF | |||
SHM | 48.11 | N/A | N/A |
SPDR Nuveen ICE Short Term Muncpl Bd ETF | |||
QTPI | 25.66 | -0.01 | -0.04% |
North Square Rcim Tax-Advantaged Preferred And Income Securities ETF | |||
IDNA | 24.48 | -0.06 | -0.24% |
iShares Genomics Immnlgy & Hlthcr ETF |